Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 16.7419.2319.8816.4017.83

What is the latest Core EBITDA Margin ratio of LINCOLN PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of LINCOLN PHARMACEUTICALS is 16.74 based on Mar2023 Consolidated results.
Year Core EBITDA Margin
Mar202316.74
Mar202219.23
Mar202119.88
Mar202016.40
Mar201917.83

How is Core EBITDA Margin of LINCOLN PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2023 16.74
-12.95
Mar2022 19.23
-3.27
Mar2021 19.88
21.22
Mar2020 16.4
-8.02
Mar2019 17.83 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,164.5 Cr -3.7% -4.6% 47.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹363,535.0 Cr 0.9% -6.6% 58.8% Stock Analytics
CIPLA ₹112,058.0 Cr -1% -5.6% 54.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,414.0 Cr 0.9% 2.2% 27.3% Stock Analytics
DIVIS LABORATORIES ₹103,845.0 Cr -2.2% 6.2% 21.2% Stock Analytics
ZYDUS LIFESCIENCES ₹98,676.3 Cr 2.8% -0.6% 96.2% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-3.7%

-4.6%

47.7%

SENSEX

-1.6%

-0.5%

19.8%


You may also like the below Video Courses